Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 8:82:104595.
doi: 10.1016/j.amsu.2022.104595. eCollection 2022 Oct.

Ethosomes: A novel drug carrier

Neha Chauhan  1 , Parul Vasava  1 , Sharuk L Khan  2 , Falak A Siddiqui  2 , Fahadul Islam  3 , Hitesh Chopra  4 , Talha Bin Emran  3   5
Affiliations

Ethosomes: A novel drug carrier

Neha Chauhan et al. Ann Med Surg (Lond). .

Abstract

Ethosomal systems are newer lipid vesicular carriers that have been around for 20 years, but over that period they have grown significantly as a means of transdermal drug delivery. They have a sizable amount of ethanol in them. These nanocarriers carry medicinal substances with various physicochemical qualities throughout the skin and deep skin layers. Since they were created in 1996, ethosomes have undergone substantial investigation; new substances have been added to their original composition, creating new varieties of ethosomal systems. These innovative carriers, which can be added to gels, patches, and lotions, are prepared using several novel methods. In addition to clinical trials, many in vivo models are employed to assess the effectiveness of dermal/transdermal administration. This review focuses on different generation of ethosomes and their comparison with other conventional liposomes.

Keywords: Applications; Ethosomes; Proteins and peptides delivery; Transdermal delivery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Fig. 1
Fig. 1
Ethosomal subtypes [11].
See this image and copyright information in PMC

References

    1. Prausnitz M.R., Mitragotri S., Langer R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 2004;3:115–124. doi: 10.1038/nrd1304. - DOI - PubMed
    1. Prausnitz M.R., Langer R. Transdermal drug delivery. Nat. Biotechnol. 2008;26:1261–1268. doi: 10.1038/nbt.1504. - DOI - PMC - PubMed
    1. Schoellhammer C.M., Blankschtein D., Langer R. Skin permeabilization for transdermal drug delivery: recent advances and future prospects. Expet Opin. Drug Deliv. 2014;11:393–407. doi: 10.1517/17425247.2014.875528. - DOI - PMC - PubMed
    1. Mezei M., Gulasekharam V. Liposomes - a selective drug delivery system for the topical route of administration I. Lotion dosage form. Life Sci. 1980;26:1473–1477. doi: 10.1016/0024-3205(80)90268-4. - DOI - PubMed
    1. Touitou E. Composition for applying active substances to or through the skin. US Pat. 1998;5:716. 638.